Laboratory Corp. (LH) Tops Q4 EPS by 3c; Guides FY12
Tweet
Share
E-mailGet Alerts LH Hot Sheet
Price: $326.89 -1.39%
Revenue Growth %: +5.3%
Financial Fact:
Amortization of intangibles and other assets: 41.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.3%
Financial Fact:
Amortization of intangibles and other assets: 41.1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Laboratory Corp. (NYSE: LH) reported Q4 EPS of $1.56, $0.03 better than the analyst estimate of $1.53. Revenue for the quarter came in at $1.37 billion versus the consensus estimate of $1.38 billion.
Sees FY2012 EPS of $6.75-$7.05, versus the consensus of $6.93.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Sees FY2012 EPS of $6.75-$7.05, versus the consensus of $6.93.
For earnings history and earnings-related data on Laboratory Corp. (LH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
